Trials / Unknown
UnknownNCT02728414
Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Type 2 Diabetes
Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Type 2 Diabetes: a Randomized, Double-blind Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Shanghai 10th People's Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the probiotics is effective in the treatment of type 2 diabetes.
Detailed description
This study aims to evaluate the effect of probiotics on the improvement of glucose and lipid metabolism, as well as the gut microbiota.Baseline, 1 month and 3 month data will be collected and put into analysis to provide some suggestions on the probiotics use in the clinical practice for type 2 diabetes patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | probiotics | the patients in this arm will receive probiotics with a dose for 2g/d for 3 months. |
| DIETARY_SUPPLEMENT | placebo | the patients in this arm will receive placebo intervention |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2016-04-05
- Last updated
- 2017-03-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02728414. Inclusion in this directory is not an endorsement.